Innovative Product Line AYMES develops a diverse range of oral nutritional supplements including vegan options and disease-specific formulas like ActaGain 2.4 Complete Maxi, positioning it well to meet specialized patient needs and expand into niche healthcare markets.
Recent Market Launches The recent launch of ActaGain 2.4 Complete Maxi and the award-winning ActaSolve Smoothie highlight the company's commitment to innovative, high-quality products, offering opportunities to gain traction among healthcare providers seeking effective nutritional solutions.
Recognition & Credibility Receiving industry awards such as the New Product of the Year 2020 enhances AYMES’s credibility and visibility, facilitating easier entry and stronger partnerships within healthcare institutions and nutrition-focused markets.
Growing Market Focus With a revenue range between 10 and 25 million dollars and a focus on health-conscious, vegan, and disease-specific populations, AYMES offers sales opportunities in both traditional healthcare and wellness sectors targeting specialized dietary needs.
Strategic Positioning As a B-Corp with a focus on cost-effective, great-tasting nutritional solutions, AYMES aligns with the increasing demand for ethical, sustainable healthcare products, opening avenues for collaborations with health-conscious retail and healthcare organizations.